Switch to:
ISIS Pharmaceuticals Inc (NAS:ISIS)
EV/Revenue
33.95 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, ISIS Pharmaceuticals Inc's enterprise value is \$7,271.1 Mil. ISIS Pharmaceuticals Inc's revenue for the trailing twelve months (TTM) ended in Dec. 2014 was \$214.2 Mil. Therefore, ISIS Pharmaceuticals Inc's EV/Revenue ratio for today is 33.95.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, ISIS Pharmaceuticals Inc's stock price is \$63.37. ISIS Pharmaceuticals Inc's revenue per share for the trailing twelve months (TTM) ended in Dec. 2014 was \$1.82. Therefore, ISIS Pharmaceuticals Inc's P/S Ratio for today is 34.82.

Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ISIS Pharmaceuticals Inc's EV/Revenue for today is calculated as:

 EV/Revenue = Enterprise Value (Today) / Revenue (TTM) = 7271.142 / 214.161 = 33.95

ISIS Pharmaceuticals Inc's current Enterprise Value is \$7,271.1 Mil.
ISIS Pharmaceuticals Inc's Revenue for the trailing twelve months (TTM) ended in Dec. 2014 was 28.161 (Mar. 2014 ) + 57.076 (Jun. 2014 ) + 44.063 (Sep. 2014 ) + 84.861 (Dec. 2014 ) = \$214.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ISIS Pharmaceuticals Inc's P/S Ratio for today is calculated as:

 P/S Ratio = Share Price (Today) / Revenue Per Share (TTM) = 63.37 / 1.82 = 34.82

ISIS Pharmaceuticals Inc's share price for today is \$63.37.
ISIS Pharmaceuticals Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Dec. 2014 was 0.24 (Mar. 2014 ) + 0.49 (Jun. 2014 ) + 0.37 (Sep. 2014 ) + 0.72 (Dec. 2014 ) = \$1.82.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

ISIS Pharmaceuticals Inc Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 ev2rev 10.76 55.22 23.23 10.23 5.55 6.34 4.59 7.52 28.62 32.79

ISIS Pharmaceuticals Inc Quarterly Data

 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 ev2rev 11.40 7.52 12.69 24.00 31.34 28.62 35.44 24.47 24.57 32.79
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)